Approval · Notice of Compliance 23244 · 2020
ACETYLCYSTEINE SOLUTION: Notice of Compliance 23244
Issued February 24, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23244
- Date
- February 24, 2020
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Labelling Only
- Reason
- Submitted in response to an adviosement letter dated november 15 2019 and update to the product monograph to the 2016 template
- Canadian reference product
- MUCOMYST
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACETYLCYSTEINE SOLUTION | Not yet assigned | — |
Medicinal ingredients
- ACETYLCYSTEINE 200 MG per ML